Skip to main content
OpenTrials
Completed

NCT Number: NCT00731068

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

To review the influence of patient derived PRGF on the healing process of Achilles tendon after a surgical correction of a complete tear.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Achilles Tendon Tear

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

About this study

Autologous platelet-rich matrices may aid in post surgical patients by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A complete tear of Achilles tendon
  • Age 18-50 years old

Exclusion criteria

  • under 18 year of age
  • pregnancy
  • physical or mental disabilities

Treatment and study plan

PRGF

Biological

injection of 6cc into injured area of tendon

Other names: platelet-derived preparation rich in growth factors

Placebo

Biological

injection of 6 cc of saline into injured area

Other names: saline 0.9% nacl

Primary outcomes

  1. improvement of symptoms / disease progress

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Official study title

PRP as a Treatment for ACHILLES Tendon Tears - Randomized-Double-Blind-Placebo Control Trail

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Aug 8, 2008
Registry last updated
Oct 24, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.